SCOTTISH MEDICINES CONSORTIUM

PRODUCT ASSESSMENT TIMELINES 2017/2018

2017

Deadline for Company Submission to Secretariat
By 12 Noon / New Drugs Committee (NDC) Meeting Date / NDC Draft Advice to Company / Deadline for Patient Submissionto SMC
By 12 Noon / Deadline for Company Response to SMC / SMC Meeting Date / Advice issued to Manufacturer/NHS Scotland / Advice issued to ComparatorCompany for Comment ** / Deadline for Comparator Comments / Advice published on SMC Website
(after 2.00 pm)
9 Jan / 28 Feb / 3 Mar / 6 Mar / 17 Mar / 4 April / 7 April / 10 April / 17 April / 8 May
6 Feb / 28 Mar / 31 Mar / 3 April / 14 Apr / 2 May / 5 May / 8 May / 15 May / 12 June
6 Mar / 25 April / 28 April / 1 May / 12 May / 6 June / 9 June / 12 June / 19 June / 10 July
3 April / 30 May / 2 June / 5 June / 16 June / 4 July / 7 July / 10 July / 17 July / 7 Aug
1 May / 27 June / 30 June / 3 July / 14 July / 1 Aug / 4 Aug / 7 Aug / 14 Aug / 11 Sept
5 June / 25 July / 28 July / 31 July / 11 Aug / 5 Sept / 8 Sept / 11 Sept / 18 Sept / 9 Oct
3 July / 29 Aug / 1 Sept / 4 Sept / 15 Sept / 3 Oct / 6 Oct / 9 Oct / 16 Oct / 13 Nov
7 Aug / 26 Sept / 29 Sept / 2 Oct / 13 Oct / 7 Nov / 10 Nov / 13 Nov / 20 Nov / 11 Dec
4 Sept / 31 Oct / 3 Nov / 6 Nov / 17 Nov / 5 Dec / 8 Dec / 11 Dec / 18 Dec / 15 Jan
2 Oct / 28 Nov / 1 Dec / 4 Dec / 15 Dec / 9 Jan / 12 Jan / 15 Jan / 15 Jan / 12 Feb
- / *** / - / 9 Jan / - / 6 Feb / 9 Feb / 12 Feb / 19 Feb / 12 Mar
6 Nov/4 Dec / 30 Jan / 2 Feb / 5 Feb / 16 Feb / 6 Mar / 9 Mar / 12 Mar / 19 Mar / 9 April

2018

Deadline for Company Submission to Secretariat
By 12 Noon / New Drugs Committee (NDC) Meeting Date / NDC Draft Advice to Company / Deadline for Patient Submissionto SMC
By 12 Noon / Deadline for Company Response to SMC / SMC Meeting Date / Advice issued to Manufacturer/NHS Scotland / Advice issued to ComparatorCompany for Comment * / Deadline for Comparator Comments / Advice published on SMC Website
(after 2.00 pm)
8 Jan / 27 Feb / 2 Mar / 5 Mar / 16 Mar / 3 Apr / 6 Apr / 9 Apr / 16 Apr / 7 May
5 Feb / 27 Mar / 30 Mar / 2 Apr / 13 Apr / 1 May / 4 May / 7 May / 14 May / 11 Jun
5 Mar / 24 Apr / 27 Apr / 30 Apr / 11 May / 05 Jun / 8 Jun / 11 Jun / 18 Jun / 9 July
2 Apr / 29 May / 1 Jun / 4 Jun / 15 Jun / 3 Jul / 6 Jul / 9 Jul / 16 Jul / 13 Aug
30 April / 26 Jun / 29 Jun / 2 Jul / 13 Jul / 7 Aug / 10 Aug / 13 Aug / 20 Aug / 10 Sep
4 Jun / 31 Jul / 3 Aug / 6 Aug / 17 Aug / 4 Sep / 7 Sep / 10 Sep / 17 Sep / 8 Oct
2 Jul / 28 Aug / 31 Aug / 3 Sep / 14 Sep / 2 Oct / 5 Oct / 8 Oct / 15 Oct / 12 Nov
6 Aug / 25 Sep / 28 Sep / 1 Oct / 12 Oct / 6 Nov / 9 Nov / 12 Nov / 19 Nov / 10 Dec
3 Sep / 30 Oct / 2 Nov / 5 Nov / 16 Nov / 4 Dec / 7 Dec / 10 Dec / 17 Dec / 14 Jan
1 Oct / 27 Nov / 30 Nov / 3 Dec / 14 Dec / 8 Jan / 11 Jan / 14 Jan / 21 Jan / 11 Feb
- / ** / - / 7 Jan / - / 5 Feb / 8 Feb / 11 Feb / 18 Feb / 11 Mar
5 Nov
3 Dec / 29 Jan
10 Dec / 1 Feb / 4 Feb / 15 Feb / 5 Mar / 8 Mar / 11 Mar / 18 Mar / 8 Apr
  • Deadline for company submission to secretariat is a guide only and does not guarantee review at the next available meeting.
  • SMC will evaluate submissions received and resources available which will determine the number of products assessed per meeting.
  • Company submission deadline dates have been temporarily removed for medicines for end of life and very rare conditions. Submissions for these medicines will be scheduled for assessment in order of date and time received. Please see Patient and Clinical Engagement (PACE).
  • Company Submission and Patient Interest Group Submission must be emailed to the SMC Secretariat by 12 Noon.
  • * If there is a change to the Detailed Advice Document resulting from comparator comments, the manufacturer and NHS Boards are sent a revised copy of the DAD prior to publication on the SMC website.
  • ** A New Drugs Committee Meeting will not be scheduled in December.

SMC Product Assessment Timelines 2017/2018